247
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Emerging Moxifloxacin Resistance in Pseudomonas aeruginosa Keratitis Isolates in South India

, , , , , , , , , , , & show all
Pages 155-158 | Received 26 Oct 2012, Accepted 10 Jan 2013, Published online: 10 May 2013

REFERENCES

  • Whitcher J, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79:214–221
  • Shah A, Sachdev A, Coggon D, et al. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br J Ophthalmol 2011; 95:762–767
  • Mather R, Karenchak LM, Romanowski EG, et al. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463–466
  • Chaudhary N, Flynn HW, Murray TG, et al. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 1999;128:509–510
  • Kunimoto D, Sharma S, Garg P, et al. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: emerging resistance. Ophthalmology 1999;106:80–85
  • Moshirfar M, Mirzaian G, Feiz V, et al. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refractive Surg 2006;32:515–518
  • Srinivasan M, Mascarenhas J, Rajaraman R, et al. The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol 2012;130:143–150
  • Wilhelmus K, Liesegang TJ, Osato MS, et al. Laboratory diagnosis of ocular infection. In: Specter S, ed. Cumitech: cumulative techniques and procedures in clinical microbiology. American Society for Microbiology Press, 1994
  • Andrews J, for the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 8). J Antimicrobial Therapy 2009;64:454–489
  • Hsu H, Nacke R, Song J, et al. Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states. Eye Contact Lens 2010;36:195–200
  • Drlica K, Zhao X. Mutant selection window hypothesis updated. Clin Infectious Dis 2007;44:681–688
  • Epstein S, Bottone D, Asbell P. Susceptibility testing of clinical isolates of Pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating Pseudomonas ocular infections. Eye Contact Lens 2006;32:240–244
  • Fintelmann R, Hoskins ES, Lietman TM, et al. Topical fluoroquinolone use as a risk factor for in vitro resistance in ocular cultures. Arch Ophthalmol 2011;129:399–402
  • Milder E, Vander J, Shah C, et al. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 2012;119:1420–1424
  • Lalitha P, Srinivasan M, Manikandan P, et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infectious Dis 2012;54:1381–1387

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.